36 computer-programmer-"the"-"U"-"U.S"-"IMPRS-ML"-"FEMTO-ST"-"CSIRO" positions at University of Copenhagen
Sort by
Refine Your Search
-
of Biology, E-mail: lellgaard@bio.ku.dk, Direct Phone: +4532351725, website: https://www1.bio.ku.dk/english/research/bms/pbg/le/ . The PhD programme Depending of your level of education, you can undertake the
-
The Novo Nordisk Foundation Quantum Computing Programme (NQCP) center at the Niels Bohr Institute, Faculty of Science at the University of Copenhagen, is seeking a graphical designer and SOME expert
-
students. We need new DEI approaches that bridge gender and neurodiversity in computer science. NeuroGen Computing Research Project builds upon the FemTech research program , and has the long-term vision
-
Nordisk Foundation Quantum Computing Programme (NQCP) is establishing a talented and diverse international team to create a cutting-edge quantum programme in the heart of Copenhagen, Denmark. At the Niels
-
funded through the EU Research Framework Programme? Horizon Europe - MSCA Is the Job related to staff position within a Research Infrastructure? No Offer Description PhD fellowship in Membrane Filtration
-
Hours Per Week 37 Offer Starting Date 1 Mar 2026 Is the job funded through the EU Research Framework Programme? Horizon Europe - MSCA Is the Job related to staff position within a Research Infrastructure
-
Professor Dorthe Varning Poulsen The PhD programme The PhD programme is a three year full-time study within the framework of the regular PhD programme (5+3 scheme), if you already have an education
-
2026 or after agreement and is a fixed-term, 2-year appointment at 30 hours per week. About the Programme Cognition and Communication is an international master’s programme offered at the Department
-
the Faculty of Health and Medical Sciences, University of Copenhagen. Job description As a group leader, you will establish an independent research program within translational diabetes type 1 research. Your
-
translational research program exploring how radiotherapy (RT) reshapes the tumor microenvironment and how these changes can be therapeutically exploited using antibody–drug conjugates (ADCs). The overall goal is